Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme (Q34871632)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme |
scientific article |
Statements
1 reference
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme (English)
1 reference
David A Reardon
1 reference
Tom Mikkelsen
1 reference
Timothy F Cloughesy
1 reference
Karen L Fink
1 reference
Alison O'Neill
1 reference
Scott Plotkin
1 reference
Michael Glantz
1 reference
Paula Ravin
1 reference
Jeffrey J Raizer
1 reference
Keith M Rich
1 reference
David Schiff
1 reference
William R Shapiro
1 reference
Susan Burdette-Radoux
1 reference
Edward J Dropcho
1 reference
Sabine M Wittemer
1 reference
Johannes Nippgen
1 reference
Martin Picard
1 reference
L Burt Nabors
1 reference
3 November 2008
1 reference
1 reference
26
1 reference
34
1 reference
5610-5617
1 reference
Identifiers
1 reference
1 reference